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Abstract
Context—Measuring the quality of the dying experience is important for hospice providers. 
However, few instruments exist that assess the quality of one’s dying; and those that do, have not 
been well validated in hospice.
Objectives—This study tested the properties of the Quality of Death-Hospice Scale (QOD-
Hospice) to provide preliminary validation data on internal consistency, inter-rater reliability, 
convergent validity and factorability in a hospice setting. Additionally, results of the factor 
analysis were used to create a brief version of the measure.
Methods—Bereaved informal caregivers who had provided care for a hospice patient were 
recruited from a large non-profit hospice. Participants completed post-death surveys, which 
included the QOD-Hospice and other study measures. Convergent validity was tested by exploring 
hypothesized associations with related instruments measuring: negative emotional states 
(Depression Anxiety Stress Scale-21); emotional grief (Texas Revised Inventory of Grief-2); 
social support (Lubben Social Network Scale-6); and a single item measure of satisfaction with 
hospice care.
Results—Seventy caregivers participated in the survey (40 primary caregivers, 30 secondary 
caregivers), most of whom were female (67%) and white (81%). The QOD-Hospice produced an 
alpha of 0.86, an intraclass correlation of 0.49 between caregivers of the same decedent, and was 
correlated with all measures testing convergent validity (P<0.05; in the hypothesized direction) 
and most, but not all, subscales. An exploratory factor analysis elicited two factors, Preparation 
(seven items) and Security (six items), which were combined to create a 13-item version of the 
scale, the QOD-Hospice-SF.
Conclusion—Although further testing of the QOD-Hospice measures is needed, preliminary 
evidence suggests the instruments are reliable and valid for use in hospice.
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Introduction
Hospice is an interdisciplinary, patient/family-oriented model of end-of-life care that 
emphasizes the comfort, dignity and quality of life. Approximately 45% of U.S. deaths 
occur while hospice support is involved.1 Although a primary goal of hospice is to ensure 
the patient’s dying experience is as good as it can possibly be,1 measuring quality of dying 
is especially challenging, in part because of the need to rely on proxy informants when 
patients cannot respond for themselves. Additionally, few instruments exist that provide a 
global assessment of one’s dying, and those that do, either have not been well validated in 
hospice, are potentially burdensome (e.g., complicated or lengthy), or have not been tested 
within the U.S. The lack of well-validated measures to assess quality of dying has direct 
implications for quality improvement in hospice. Without valid measures, hospices may be 
unable to determine their successes or failures on this crucial outcome; and thus, unable to 
adjust their practice behaviors accordingly. Furthermore, if hospices cannot monitor quality 
of dying, patients may be needlessly suffering without the awareness of providers. This 
study builds on previous research on quality of dying to evaluate the measurement properties 
of a new scale, the Quality of Dying-Hospice (QOD-Hospice).
Steinhauser and colleagues2 interviewed dying patients, their families and providers, and 
identified five domains related to quality of life at the end of life: completion; relationship 
with the health care system; preparation; symptom impact; and affective social support. 
Munn et al.3 built upon this work, identifying six factors related to quality of dying in long-
term care. Hales, Zimmerman and Rodin4 summarized the literature on quality of dying and 
death to elicit seven domains: physical; psychological; social; spiritual and existential 
experience; the nature of health care; life closure and death preparation; and the 
circumstances of death. These studies provided the empirically derived conceptual domains 
targeted by the QOD-Hospice scale (see Cagle,5 Munn3 and Steinhauser2 for more 
information on the conceptual underpinnings of the scale).
Although a full review of existing measures is beyond the scope of this article (see Hanson 
et al.6), it is important to highlight measures that have been developed to monitor quality of 
dying and related outcomes. In a recent review of quality measures appropriate for 
hospice,6,7 only one instrument was identified to evaluate quality of dying – the Quality of 
Dying and Death (QODD).8,9 The QODD is a 31-item instrument designed to assess the 
quality of the dying experience from the perspective of bereaved family members. The scale 
demonstrated good reliability (α = 0.89) and acceptable factorial and construct validity. The 
measure has been recommended for use with end-of-life populations.10
The QODD was developed using interviews with surviving family members between one to 
three years after the death. Because of the substantial time since death, respondents were 
susceptible to recall bias. Additionally, the original version of the QODD implied that 
hospice is a location by asking respondents’ to report the decedent’s place of death using 
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three mutually exclusive options: home, hospice, or hospital.9 Furthermore, in the hospice 
validation study, developers of the QODD excluded families when a patient’s illness was 
too severe (i.e., estimated survival of less than two weeks or could not complete a pre-death 
interview).10
The Palliative Care Outcomes Scale (POS)11 also has been endorsed for use in end-of-life 
care settings.10 Originally designed for oncology patients, it has since been used with non-
cancer populations. It has two versions: one for health care staff, one for patients. In the 
development study, the POS showed marginal internal consistency (α = 0.65 patients; α = 
0.70 staff) and test-retest reliability for patients during consecutive clinic visits with raw 
agreement (mostly >80%) and greatly exceeding kappas (0-0.6). More recently, the POS 
was modified for use with bereaved family members and found to have high ratings of 
relevance, moderate correlations with other end-of-life measures, and modest reliability (α = 
0.64).12 The POS, however, has not been well-validated in hospice settings. STARTSTART
Despite the availability of some promising measures that capture key end-of-life processes 
and outcomes, there is limited evidence about the applicability of these measures in hospice 
settings. Furthermore, currently available measures have been generally criticized for 
lacking clear conceptual frameworks, poorly described development processes, or limited 
empirical evaluation.8,10,13 To address these concerns, end-of-life researchers and advocates 
have called for further development and testing of instruments to assess outcomes near death 
– particularly measures of quality-related factors.8,10,13 In response to this call, we 
developed and tested the QOD-Hospice for use within hospice settings. We crafted the 
measure to be a conceptually grounded, low burden measure to evaluate a patient’s quality 
of dying from the perspective of a close family member or caregiver. If the instrument 
withstands empirical scrutiny, the tool will have broad applications for research and quality 
improvement in hospice. Thus, the purpose of this study was to provide preliminary 
validation data on the QOD-Hospice including general instrument properties, internal 
consistency, inter-rater reliability and convergent validity. Additionally, we used a factor 
analysis to produce a brief version of the measure. An item-by-item correspondence with 
key conceptual domains is also provided.
Methods
Design
After a brief pilot study, data were collected from a prospective bereavement study in 
2008-2009 using two self-administered mailed questionnaires (a pre-death and post-death 
survey) to examine short-term bereavement outcomes for informal caregivers of hospice 
cancer patients. With the exception of demographic characteristics, the data presented here 
come exclusively from the post-death survey wave. Participants were sent the post-death 
survey three months after the patient’s death. Three months after a death is a conventional 
time point for evaluating short-term bereavement outcomes14 and the earliest post-death 
data collection period agreed upon by the approving Institutional Review Boards (Virginia 
Commonwealth University and Florida State University) and participating hospice.
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Development of the QOD-Hospice
The QOD-Hospice scale was adapted from the Quality of Dying in Long-Term Care (QOD-
LTC) long form3 and, by extension, the Quality of Life at the End of Life (QUAL-E) 
scale.2,15, Twenty items of the QOD-Hospice scale were selected from 36 items of the 
QOD-LTC by the authors based on their applicability to the broad range of settings within 
which hospice operates (e.g., private residences, hospitals, nursing homes), and conceptual 
comprehensiveness based on the literature.3,4,15 Of the twenty items selected for the QOD-
Hospice scale, one item regarding place of death was created: “My loved one’s wishes were 
met regarding the place of death”; and ten items were modified, for example, to reflect a 
team approach: “There was a [added: hospice staff member] with whom my loved one felt 
comfortable.”
Sample
Participants were informal caregivers recruited consecutively from a large southeastern 
hospice in 2008. Potential study participants were identified within 48 hours of admission by 
hospice social workers using the following criteria: the patient had 1) a primary diagnosis of 
cancer and 2) at least one informal caregiver. Participation was limited to informal 
caregivers of cancer patients as this population was the focus of the larger study.5,16 
Informal caregivers were defined as any person, other than paid staff, that the patient (or 
proxy) identified as a provider of physical, psychological, emotional, or financial assistance; 
were 18 years of age or older; and were literate in English. In many cases, multiple 
caregivers were identified within the same family, in which case all were invited to 
participate.
A total of 253 eligible informal caregivers of 104 patients were identified during admission 
to hospice. In 15% (39) of caregiver cases, the patient died prior to consent contact (one 
week of admission) and, thus, these caregivers were not asked to participate. Recruitment of 
caregivers of living hospice patients was a requirement of the larger study because of its 
prospective design. In 28 (11%) of the caregiver cases, the patient or family declined to 
share their contact information with the research team. Fifty-five caregivers (22%) did not 
provide consent by mail (i.e., did not return the pre-death survey). In three cases (1%), the 
contact information was invalid. The remaining 128 (51%) provided informed consent and 
agreed to participate in the bereavement wave of the study. Post-death surveys were mailed 
to these 128 informal caregivers of 78 decedents. A total of 80 surveys were returned, for a 
response rate of 63%. All post-death surveys were received within ten weeks from when the 
survey was initially mailed (i.e., three months post-death). Ten cases were removed from the 
sample for having >25% of items missing on key measures; thus the final analytic sample 
was set at 70 (55% of the sample, related to 40 decedents).
Measures
The Quality of Dying-Hospice—The QOD-Hospice is a 20-item scale designed to 
measure perceived quality of dying. It is administered retrospectively, asking bereaved 
family members to reflect on a decedent’s final month of life. We elected the one month 
time frame based on suggestions that patients need at least one month of hospice before they 
receive the full benefits of its services.17 The measure presents statements pertaining to 
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quality of dying using a five-point response set, 1=not at all to 5=completely. A “don’t 
know” option also was provided because respondents are asked about information that they 
may not know or recall. Completed items are summed then divided by the total number of 
completed items to produce a score (possible range 1-5). Higher scores indicate better 
quality of dying.
To document preliminary evidence about the QOD-Hospice scale’s construct validity, we 
tested associations with four conceptually related (but not synonymous) instruments 
measuring caregivers’: 1) negative emotional states; 2) emotional grief; 3) social support; 
and 4) satisfaction with hospice care. Based on evidence from the existing literature,4,15,18,19 
we expected the following measures to converge on the QOD-Hospice scores with 
moderate, but statistically significant, correlation coefficients (i.e., an examination of 
convergent validity).
Depression Anxiety Stress Scale-21 (DASS-21)—The DASS-21 is a 21-item 
questionnaire assessing negative emotional states.20 It comprises three seven-item subscales 
(depression, anxiety, and stress) and a four-point response set to investigate affective state 
over the past week. Building from previous evidence,4,19 the DASS-21 and its subscales 
were hypothesized to be negatively associated with quality of dying. The DASS-21 has been 
evaluated with hospice caregivers, with all subscales demonstrating good reliability and 
validity.21 Furthermore, a large sample of non-clinical respondents produced reliability 
estimates of 0.88 for depression, 0.82 for anxiety, 0.90 for stress, and 0.93 overall.22
Texas Revised Inventory of Grief-2 (TRIG-2)—The TRIG-2 is a 13-item assessment 
of emotional grief using a five-point response scale ranging from “completely true” to 
“completely false.”23 The TRIG-2 has shown good reliability (alphas from 0.8 to 0.95) and 
adequate validity.23,24 Based on prior studies,4,14,24 quality of dying was expected to 
negatively correlate with levels of affective grief.
Lubben Social Network Scale- 6 (LSNS-6)—The LSNS-6 measures perceived social 
support using two three-item subscales: “Family” and “Friendships.”25 Lubben and 
colleagues25,26 found acceptable reliability coefficients for the entire scale (α= 0.83) and 
subscales (0.80-0.89). Based on prior research,4,15,18,19 a positive relationship between the 
LSNS-6 subscales and quality of dying was hypothesized.
Satisfaction With Hospice Care—Satisfaction with care was assessed with the item: 
“Overall, how satisfied/dissatisfied are you with the care that hospice provided?” Response 
options ranged from 1=very dissatisfied to 5=very satisfied. Respondents’ satisfaction with 
hospice care was hypothesized to be positively correlated with the QOD-Hospice scale.18,19
Statistical Analysis
PASW SPSS 18.0 (SPSS Inc., Chicago, IL) was used for statistical analyses. Data were 
prescreened for outliers and missing values. Missing items were substituted using the 
expectation maximization method appropriate for validity testing.27,28 Construct validity of 
the QOD-Hospice was evaluated with: 1) a convergent test examining associations with 
conceptually related measures – the LSNS-6, DASS-21, TRIG-2, and care satisfaction; 2) an 
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exploratory factor analysis (EFA) exploring the measure’s structure. EFA was deemed 
appropriate despite the limited sample size.29 To determine the number of factors, the study 
used parallel analysis with direct oblimin rotation.30 For factor selection, we used a 
conservative loading threshold of 0.50 to ensure parsimony and interpretability.31 To 
examine measurement reliability, the following estimates were calculated: Cronbach’s alpha 
for internal consistency; percentage agreement (i.e., the proportion of scale scores falling 
within one standard deviation among caregivers of the same decedent) and intraclass 
correlation (ICC) for inter-rater reliability among caregivers of the same decedent.
Stratification of Caregiver Respondents—Because multiple respondents provided 
data about the same decedent (75% of the decedent sample), it was important to account for 
clustering effects. To address potential bias, sample descriptives and measurement 
properties were stratified into two groups: primary caregivers and secondary caregivers. 
Primary caregivers were family members who were responsible for the largest portion of the 
decedent’s care. In cases where family members reported providing the same proportion of 
care, we selected the respondent who had spent the most time with the patient prior to death. 
Secondary caregivers were respondents from households in which there was already a 
primary caregiver, but who reported being less involved than the primary caregiver.
Isolating the subsample of primary caregivers ensured that the most knowledgeable observer 
was providing information about a single patient. This approach eliminated the potential for 
clustering effects at the family level. Caregiver groups were combined when exploring 
associations between study variables to ensure adequate sample size for respective tests.
Results
Descriptive Statistics
Table 1 summarizes the sample characteristics of caregiver respondents and patients (i.e., 
decedents). A total of 70 caregivers were included in the sample, including 40 (57%) 
primary caregivers. Two-thirds (67%) of the total sample of caregivers was female, the 
majority white (81%) with a mean age of 58 years (SD = 12.8). Compared with secondary 
caregivers, primary caregivers were more likely to be the patient’s spouse (51% vs. 4%, 
P<0.001), older (61 vs. 54 years, P<0.05), and co-residing with the patient (65% vs. 7%, 
P<0.001). Exactly half of decedents were male, and 33% had a cancer diagnosis other than 
the eight diagnostic categories provided, followed by lung cancer (25%). At admission, 
patients had a median pain rating of 0 (interquartile range [IQR] = 0 - 4) on a 0-10 scale and 
were moderately functional (median Palliative Performance Scale score of 40%, IQR = 40 - 
50). The median length of stay in hospice was 60 days (IQR = 25 - 91). None of the 
observed patient characteristics differed between primary and secondary caregiver groups.
Before testing convergent validity, measurement characteristics of the five variables of 
interest were calculated for the entire sample, and subsamples of primary and secondary 
caregivers (Table 2). The QOD-Hospice, LSNS-6, DASS-21, and TRIG-2 had high alphas 
for the combined sample, as well as for primary and secondary caregivers when examined 
separately. On average, primary caregivers scored a 4.44 (SD=.48) on the QOD-Hospice and 
secondary caregivers produced a similar score 4.40 (SD=.49).
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Missing data on the QOD-Hospice scale were low. Only 1% of items were left blank. 
Responses of “don’t know” were more prevalent than items left blank, but still relatively 
low, averaging 4% per item. The item with the most “don’t know” responses was whether 
the decedent’s treatment preferences were in writing (n=8, 11%). Incomplete data (actual 
missing and “don’t know”) were related to involvement in care (P=0.002), with lesser 
involved caregivers having more incomplete data.
Factor Analysis
Factorability of the 20-item QOD-Hospice scale was examined using three criteria. First, 
individual items were correlated with remaining items (r > 0.30 in all cases) suggesting good 
factorability. Next, the Kaiser-Meyer-Olkin measure of sampling adequacy had an 
acceptable score of 0.60, and Bartlett’s test of sphericity was also significant (P<0.001). 
Lastly, only items with communalities above 0.30 were selected. Thus, the assumptions of 
EFA were supported.31
A scree plot was used to determine factors for inclusion in a short-form measure. Seven 
factors had eigenvalues >1. Two factors were greater than the mean and 95th percentile of 
the parallel analysis (Fig. 1) and, therefore, selected.30,32 For factor extraction, the EFA 
produced loadings for all 20 QOD-Hospice items using these two factors.
Table 3 reports results of the EFA with factor loadings by QOD-Hospice item. The two 
identified factors explained 42% of the variance. The first factor, labeled “Preparation,” 
consisted of seven items explaining 29% of the overall variance. The item with the highest 
loading (0.82) was: “My loved one indicated he/she was prepared to die.” Conceptually, this 
label captures elements pertinent to a patient being prepared for their own dying and death, 
including advance care planning, “closure,” maintaining a sense of humor, and realistic 
expectations about the illness.
The second factor, which explained 13% of the variance, comprised six items and was 
labeled “Security.” The item with the highest factor loading was: “There was someone from 
hospice whom he/she trusted.” Other items included questions covering relationships with 
hospice team members, and whether circumstances regarding the death were honored. An 
examination of factor inter-correlations produced a coefficient of 0.26, suggesting a 
relationship of moderate strength between the two factors. Given the results of parallel 
analysis, and to make a parsimonious measure, we selected these two factors and their 
combined thirteen items (all of which had loadings >0.50) in a new measure. The resulting 
short-form instrument is heretofore referred to as the QOD-Hospice-SF.
Table 4 presents descriptive statistics for the QOD-Hospice-SF scale and subscales. In 
general, respondents rated quality of dying highly; all average scores were 4.3 or higher on a 
1-5 scale. Reliability coefficients were high: 0.85 for the QOD-Hospice-SF, 0.82 for the 
Preparation subscale, and 0.85 for the Security subscale. ICC scores indicated moderate 
agreement among caregivers from the same family, eliciting an overall ICC score of 0.64 on 
the QOD-Hospice-SF scale. The Preparation subscale showed higher agreement among 
caregivers (0.80), but the Security subscale had only fair concordance among raters (0.33). 
Similarly, the percentage of inter-rater agreement among caregivers was acceptable for both 
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scales, 63% for the QOD-Hospice and 79% for the QOD-Hospice-SF. Agreement was high 
(89%) for the Preparation subscale and acceptable (63%) for the Security subscale.
Bivariate Analysis
Convergent validity of the QOD-Hospice was examined by comparing predicted 
associations with selected study measures. Table 5 presents correlations between the two 
QOD-Hospice scales and other study measures. Using the combined sample, both versions 
of the QOD-Hospice were associated with the LSNS-6-family, DASS-21-depression, 
DASS-21-stress, and TRIG-2 (P<0.05 for all tests). All statistically significant relationships 
were in the expected direction. For example, the greater the level of family support (LSNS-6 
family subscale), the better the quality of dying. Conversely, QOD-Hospice scores were 
negatively correlated with the caregivers’ depressive symptoms, stress, and affective grief. 
A moderate, positive association (ρ =0.33, P=0.005) also was observed between QOD-
Hospice scores and satisfaction with hospice care.
Discussion
Our study provides preliminary evidence that the QOD-Hospice and QOD-Hospice-SF 
scales are reliable and valid for assessing quality of dying in hospice. Although further 
research is warranted to evaluate instrument properties across different agencies and diverse 
patient populations, our preliminary findings are promising. Based on this initial work, both 
of these instruments have good conceptual and structural integrity and are appropriate for 
research and quality measurement in hospice. We present findings from both the original 
instrument as well as the short-form version because the full instrument appears to have 
greater conceptual comprehensiveness, whereas the strength of the short form is its 
dimensionality and brevity. We also hope to encourage further testing of these new 
measures with other hospice populations.
A strength of this study was the inclusion of both primary and secondary caregivers, which 
allowed for an assessment of inter-rater reliability. Because of concerns about the validity of 
proxy reports, it is critical for observational measures of end-of-life outcomes to maintain 
consistency across different observers. Results suggest the QOD-Hospice scales have fairly 
strong agreement among observers and the Preparation subscale, in particular, demonstrated 
nearly perfect agreement. Alternately, the Security subscale produced only moderate 
agreement between raters. Lower correspondence may be explained by differing levels of 
knowledge about the circumstances of care. Primary caregivers may be in a better position 
to assess these external elements whereas secondary caregivers may be less knowledgeable 
because they are less involved. Also noteworthy, scores for both versions of the QOD-
Hospice were negatively skewed, suggesting a possible ceiling effect and a limited ability to 
detect the lower range. This skew was expected, however, as hospice users tend to rate 
outcomes highly. Furthermore, the moderate association between the two subscales suggests 
the factors are indeed conceptually distinct – and yet related – components of the quality of 
dying.
The support of friends among caregiver respondents as measured by the LSNS-6 was not 
significantly associated with either QOD measure or subscale, which suggests a lack of 
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conceptual relatedness. The Preparation subscale was consistently associated with affective 
measures (grief, depression, anxiety, stress), and satisfaction with care and social support 
from the caregiver’s family (from the LSNS-6) were the only measures significantly related 
to the Security subscale. Although the causal direction of the association cannot be 
determined with these data, perhaps a lack of patient preparation is more emotionally 
distressing for surviving family members. Future research is needed to explore the link 
between the emotional state of proxy observers and assessments of quality at the end of life. 
In terms of convergent validity and the strength of bivariate associations, some statistically 
significant associations were weaker than hypothesized (e.g., r < 0.30). For example, the full 
QOD-Hospice scale demonstrated weak associations with depressive symptoms and anxiety, 
which indicates limited relatedness between these variables. Respondent characteristics or 
environmental circumstances, other than the quality of the decedent’s death, may be more 
influential on the surviving caregiver’s symptoms of depression and anxiety.
Interestingly, based on EFA results, no physical items were included in the QOD-Hospice-
SF. Because relief from distressing physical symptoms had been identified as s critical 
component of assessments of the dying experience,4,15,18 the short form should be 
considered preliminary and warrants further testing. Related to this, the time saved by using 
the short form may not be worth reduction in conceptual comprehensiveness. However, it is 
possible that, from the perspective of informal caregivers, the personal and social 
dimensions of dying are more integral to quality of dying than physical aspects.
Findings should be interpreted within the context of study limitations. Participants were 
recruited from only one non-profit hospice. The participating hospice was large, with 13 
branch offices covering about 15,000 square miles of rural, urban and suburban regions. 
Additional data on the replicability of results in other hospices are needed. Because of the 
small, relatively homogenous make up of the sample, these data should be treated as 
preliminary. Of note, our study was limited to decedents with a primary diagnosis of cancer. 
However, the tremendous growth of the non-cancer patient population requires validity 
testing across a broader cross-section of patients. Non-response because of families electing 
to forgo participation, or other selection bias, also may limit the generalizability of results.
Another challenge for evaluating quality of dying in hospice is abbreviated length of stay. 
Half of hospice patients die within 18 days of enrollment.1 Thus, the time referent of “the 
past month” may encompass elements of care prior to hospice admission. In this regard, for 
patients who die less than one month after admission to hospice, the QOD-Hospice scales 
may capture aspects of the dying experience that extend beyond the patient’s hospice stay 
and outside of the provider’s control. Scale scores, therefore, should be considered with 
respect to length of stay. Furthermore, because hospice often relies on other caregivers (e.g., 
family members) to provide hands-on care, elements of care such as “clothes and body 
clean” may not reflect care by formal care providers. Future research should examine 
potential modifications to the QOD-Hospice scales to further accommodate patients with 
short lengths of stay.
The QOD-Hospice measures capture key elements of the quality of the dying experience 
within a variety of hospice care environments. Although the measures may help guide 
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clinical decision making, they were not created to assess the quality of care being provided 
by the hospice team. That said, hospices that encounter low ratings on that QOD-Hospice 
measures can respond by identifying items that are being consistently rated poorly and then 
employing clinical interventions to target those underperforming domains. For example, if 
providers discover that a substantial proportion of their patients’ location of death is not in 
accordance with the patients’ wishes (item 12 in Table 3), then hospice team members can 
address this deficiency by documenting the patient’s preferred place of death, 
communicating that preference to the relevant stakeholders, and proactively planning to 
ensure that the patient’s preferences are honored.
Future research should explore the optimal timing for collecting data from bereaved 
caregivers. We elected to collect bereavement data at three months after the death to limit 
burden on grieving families and yet minimize potential for recall bias. However, other 
intervals (e.g., one month, six months, one year) may prove more sensitive to the family’s 
needs or elicit more accurate data.
Our understanding and measurement of the quality of the dying experience are still evolving 
in both research and practice. As with other important health care constructs (depression and 
functionality, for example) it is important to provide researchers and clinicians with a few 
well-developed, rigorously tested instruments from which to choose. We submit that 
dissemination of the QOD-Hospice scales will allow potential users to weigh their 
respective merits and limitations relative to other measures designed to capture the dying 
experience, such as the QODD and POS.
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Table 1
Sample Characteristics for Caregivers and Decedents
Sample
Total Primary Caregiver Secondary Caregiver Pa
Caregiver Characteristics
 N 70 40 30
 Total, % 100 57.1 42.9
  Age, yrs, mean (SD) 57.7 (12.8) 60.6 (13.7) 53.7 (10.4) 0.024
  Gender, % 0.728
   Male 28.6 28.2 32.1
   Female 67.1 71.8 67.9
  Race, % 0.430
   African American 8.6 12.8 3.6
   White 81.4 82.1 89.3
   Other 5.7 5.2 6.2
  Income, % 0.359
   Less than $20,000 17.1 21.6 16.0
   $20,000 - $25,000 8.6 8.1 12.0
   $25,000 - $35,000 8.6 13.5 4.0
   $35,000 - $50,000 21.4 27.0 20.0
   $50,000 - $75,000 14.3 13.5 20.0
   Over $75,000 18.6 16.2 28.0
  Education, % 0.606
   Some high school 7.1 7.7 7.1
   High school diploma or GED 30.0 38.5 21.4
   Some college 28.6 28.2 32.1
   College degree 21.4 20.5 25.0
   Graduate school 8.6 5.2 14.3
  Employment status, % 0.219
   Full time 30.0 20.5 46.4
   Part time 7.1 7.7 7.1
   Unemployed 7.1 10.3 3.6
   Retired 47.1 53.8 42.9
   Other 4.3 7.7 0.0
  Relationship to patient, % < 0.001
   Spouse/partner 30.0 51.3 3.6
   Parent 5.7 2.6 10.7
   Child 38.6 33.3 50.0
   Sibling 14.3 10.3 21.4
   Other 7.2 2.6 14.2
  Geographic proximity, % < 0.001
   Living together 40.0 65.0 6.7
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Sample
Total Primary Caregiver Secondary Caregiver Pa
   Within 10 miles 34.3 27.5 43.3
   More than 10 miles 25.7 7.5 50.0
Patient Characteristics
  N 40
  Age, yrs, mean (SD) 76 (14.3)
  Gender, %
   Male 50.0
   Female 50.0
  Cancer diagnosis, %
   Lung & Bronchus 25.0
   Prostate 10.0
   Breast 2.5
   Brain 2.5
   Liver & Biliary 10.0
   Pancreas 10.0
   Ovarian 5.0
   Melanoma 2.5
   Other 32.5
  Place of death, %
   Home 72.5
   Nursing facility 10.0
   Palliative care unit 7.5
  Pain level (0–10) median (IQF)b 0 (0-4)
  Palliative Performance Score, median % (IQF)c 40 (40-50)
  LOS under hospice care, median days (IQF) 60 (25-91)
LOS = length of stay.
a
Comparisons of primary caregivers vs. secondary caregivers.
b
Data on patient pain at admission were obtained from the hospice medical chart: 0 = no pain; 10 = worst possible pain.
c
The Palliative Performance Scale (PPS) measures functional status on five domains: ambulation, ability to do. activities, self-care, food/fluid 
intake, and consciousness level, using deciles (increments of 10%; 100% indicating healthy; 0% indicating death).31 PPS scores at admission to 
hospice were collected from patient medical charts.
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